The Discounted Cash Flow (DCF) valuation of ADiTx Therapeutics Inc (ADTX) is (13,593,147,805.20) USD. With the latest stock price at 0.90 USD, the upside of ADiTx Therapeutics Inc based on DCF is -1510517591520.8%.
Based on the latest price of 0.90 USD and our DCF valuation, ADiTx Therapeutics Inc (ADTX) is a sell. selling ADTX stocks now will result in a potential gain of 1510517591520.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 141.3% | 73.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (3,829,196,651,892.56) - (3,354,566,993.21) | (13,593,147,805.20) |
| Upside | -425513573940822.8% - -372771085022.1% | -1510517591520.8% |